Climb Bio Stock Technical Analysis
| CLYM Stock | 1.51 0.05 3.42% |
As of the 20th of July, Climb Bio shows the Downside Deviation of 3.92, mean deviation of 3.31, and Risk Adjusted Performance of 0.0748. Climb Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Climb Bio information ratio, as well as the relationship between the potential upside and kurtosis to decide if Climb Bio is priced correctly, providing market reflects its regular price of 1.51 per share. Please also double-check Climb Bio total risk alpha, which is currently at (0.30) to validate the company can sustain itself at a future point.
Climb Bio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Climb, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ClimbClimb Bio's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Climb Bio Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 10.0 | Strong Buy | 2 | Odds |
Most Climb analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Climb stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Climb Bio, talking to its executives and customers, or listening to Climb conference calls.
Climb Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Climb Bio Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Climb Bio across different markets.
Climb Bio Trend Analysis
Use this graph to draw trend lines for Climb Bio. You can use it to identify possible trend reversals for Climb Bio as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Climb Bio price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Climb Bio Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Climb Bio applied against its price change over selected period. The best fit line has a slop of 0 , which means Climb Bio will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.17, which is the sum of squared deviations for the predicted Climb Bio price change compared to its average price change.About Climb Bio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Climb Bio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Climb Bio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Climb Bio price pattern first instead of the macroeconomic environment surrounding Climb Bio. By analyzing Climb Bio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Climb Bio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Climb Bio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 22.04 | 38.92 | 31.41 | 20.18 | Net Debt To EBITDA | 0.96 | 2.3 | 2.86 | 2.51 |
Climb Bio July 20, 2025 Technical Indicators
Most technical analysis of Climb help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Climb from various momentum indicators to cycle indicators. When you analyze Climb charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0748 | |||
| Market Risk Adjusted Performance | 0.1975 | |||
| Mean Deviation | 3.31 | |||
| Semi Deviation | 3.48 | |||
| Downside Deviation | 3.92 | |||
| Coefficient Of Variation | 1392.46 | |||
| Standard Deviation | 4.19 | |||
| Variance | 17.59 | |||
| Information Ratio | 0.0382 | |||
| Jensen Alpha | 0.0881 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0409 | |||
| Treynor Ratio | 0.1875 | |||
| Maximum Drawdown | 20.13 | |||
| Value At Risk | (6.35) | |||
| Potential Upside | 7.5 | |||
| Downside Variance | 15.4 | |||
| Semi Variance | 12.1 | |||
| Expected Short fall | (4.07) | |||
| Skewness | 0.3636 | |||
| Kurtosis | 0.0989 |
Climb Bio July 20, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Climb stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.50 | ||
| Rate Of Daily Change | 1.03 | ||
| Day Median Price | 1.50 | ||
| Day Typical Price | 1.50 | ||
| Price Action Indicator | 0.04 | ||
| Market Facilitation Index | 0.10 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.